You are here: Industry Insights > ,

News List

20 Years of Growth and Innovation in China, Fette Compacting Launches F30p Tablet Press PharmaSources
December 13, 2024
Interview Dr. Andreas Risch——Managing Director of Fette Compacting (China) Co., Ltd.
Innovative Strategies to Accelerate Drug R&D, and Regulatory Approvals Saher Haider
October 15, 2024
Global health crises, with the COVID-19 pandemic being the most predominant one, revealed the importance and the stark inefficiencies of traditional drug development pathways.
Ulinastatin in Japan, China, and India David Orchard-Webb
October 09, 2024
Ulinastatin, a naturally occurring protease modulator generated from human urine, has been used for decades to treat inflammatory disorders like sepsis, acute pancreatitis, and organ failure.
Professor James Rothman, Nobel Laureate, to Join the Board of Noscendo GmbH Biotech Newswire
August 21, 2024
Noscendo GmbH announced that Professor James Rothman has agreed to serve on its board as an independent director.
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® Demonstrates Positive Cardiovascular Safety in a Large, Real-World Evidence Study Biotech Newswire
August 28, 2024
Currax Pharmaceuticals LLC announced the results of a Cardiovascular Health Outcomes Analysis.The results showed there is no evidence of excess cardiovascular risk.
osteolabs Publishes First Real-World Evidence Data from Close to 3, 000 OsteoTest Patient Samples Biotech Newswire
August 16, 2024
osteolabs GmbH announced the publication of real-world evidence data from close to 3,000 OsteoTest patient samples in the prestigious journal Bone.
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland Biotech Newswire
June 24, 2024
The Celonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland.
New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs PharmaSources
June 05, 2024
New research showes that biotechs can save more than 30% in costs, halve start-up times, and cut risk with CROs that have in-house scientific and regulatory affairs.
Generic = Branded Drug, What are the Facts? Krebs Qin
July 03, 2024
It is no secret that the U.S. military does not trust the quality of generic drugs, and their disagreements and disagreements with the FDA over the quality control of generic drugs have long been made public.
Which pharmaceutical giant is most willing to invest, and which excels at generating profits? Krebs Qin
May 27, 2024
The significance of R&D investment in biopharmaceutical companies cannot be overstated.